US President-elect Donald Trump’s appointed Health and Human Services chief Robert F. Kennedy Jr has clashed with billionaire entrepreneur Elon Musk over the use of weight-loss medications in America. Recently, Musk revealed on social media that he takes medication Mounjaro for weight loss, dubbing himself “Ozempic Santa.”
The revelation comes after a public debate between Kennedy and Musk over the role GLP-1 inhibitors play in making Americans healthier and thinner. Musk has argued that expensive weight-loss drugs like Mounjaro are more effective than lifestyle changes or access to healthy food.
Musk initially tried Ozempic, but reported side effects like farting and burping after high doses. He claims Mounjaro has fewer side effects and is more effective for him. The medication, a GLP-1 inhibitor initially prescribed for type 2 diabetes, has been shown to help overweight adults lose up to 15% of their body weight.
The debate highlights the ongoing discussion over the best approach to tackle America’s obesity epidemic. Kennedy advocates for healthier food and lifestyle changes, while Musk believes expensive medications can make a significant difference in improving health and quality of life. As the government efficiency advisory committee head, Musk will likely play a key role in shaping Trump’s healthcare policies.
Source: https://www.independent.co.uk/news/world/americas/us-politics/elon-musk-weight-loss-mounjaro-b2670186.html